Avecho Biotechnology Limited (ASX: AVE)
Health Care · Pharmaceuticals · AU
AU$0.02
+5.00% today · +250.0% 1Y
Avecho Biotechnology Limited (ASX: AVE) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $58.16M and employs 9 people.
Over the last twelve months the share price has gained 250.0%, trading between 0.01 and 0.03.
Tweenvest scores Avecho Biotechnology Limited across four factors: quality 30/100, value 64/100, growth 59/100. Its strongest factor is value.
AVE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $58.16M
- Revenue (TTM)
- $825.62K
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 1.12
- 52-week high
- AU$0.03
- 52-week low
- AU$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 3.86B
- Employees
- 9
- Next earnings
- —
About Avecho Biotechnology Limited
Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. Its human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. In addition, the company develops pharmaceutical products; oral, topical, and edible pharmaceutical cannabinoid products, including a cannabidiol TPM soft-gel capsule in Phase III clinical trial for the treatment of insomnia; and non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.
- ISIN
- AU0000047441
- Founded
- 1992
- Listed since
- Aug 31, 1993
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.22 | -0.96% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.15 | +0.29% |
Figures last refreshed Aug 18, 2026.